Peptide Therapy Pricing Explained: What's Actually Included in the Cost

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All medical decisions are made by independent licensed clinicians. Individual results vary. Consult a qualified healthcare professional before starting any therapy.

How Peptide Therapy Pricing Works: What's Included and What to Watch For

If you've spent any time researching peptide therapy online, you've probably noticed that pricing feels deliberately opaque. Some providers list a base medication cost, then tack on consultation fees, shipping charges, and supply costs at checkout. Others quote a monthly number but bury the clinical review fee in fine print. This article breaks down how peptide therapy pricing actually works — what should be included, what gets hidden, and how to compare programs without getting blindsided. The perspective here comes from New Blue Health, a LegitScript-certified telehealth platform with over 14 years of experience in regulated health product supply chains, so the details are drawn from real operational knowledge rather than surface-level research.

What Is Peptide Therapy? A Quick Overview

Peptide therapy refers to the clinical use of specific peptide compounds — short chains of amino acids — to support various physiological processes. These compounds have been investigated in clinical trials for applications ranging from metabolic support to recovery, cellular health, and sexual wellness. They are not a single treatment but rather a category that includes distinct molecules with different mechanisms, dosing protocols, and cost structures.

For example, semaglutide and tirzepatide are GLP-1 receptor agonists that have been studied extensively for metabolic and weight-related applications. Sermorelin and tesamorelin are growth hormone-releasing compounds investigated for recovery and body composition support. NAD+ and glutathione target cellular-level processes. PT-141 (bremelanotide) has been studied for sexual wellness. GHK-Cu is a copper peptide used topically for skin and hair support. Each of these has a different cost profile based on the compound itself, the formulation, and the clinical oversight required.

The reason this matters for pricing: not all peptide therapies cost the same to produce, compound, or prescribe. A $279 NAD+ program and a $349 tirzepatide program reflect genuinely different underlying costs — not arbitrary markups. Understanding the category helps you evaluate whether a quoted price is reasonable or inflated.

Why Peptide Therapy Pricing Can Be Confusing

Pricing confusion in this space stems from three structural problems. First, there is no standard pricing format across telehealth platforms. Second, the word "consultation" means different things to different providers. Third, compounded medications exist in a regulatory and pricing category that most consumers have never encountered before.

Consider a common scenario: Provider A lists sermorelin at $199/month but charges a separate $150 consultation fee upfront, plus $15 for shipping, plus a $25 "supplies kit." Your actual month-one cost is $389. Provider B lists sermorelin at $299, all-in, with the clinical consultation, medication, supplies, and shipping included. Provider B looks more expensive at first glance — but is actually $90 cheaper.

This is not a hypothetical. It is the most common pricing confusion reported by people researching peptide therapy for the first time. The lack of standardization means you have to read the fine print on every single provider's site, and most people don't.

A second layer of confusion: some platforms quote per-vial pricing without specifying the supply duration. A "$150 vial" that lasts 10 days is more expensive per month than a "$299 program" that covers a full month. Always convert pricing to a per-day or per-30-day basis before comparing.

What All-In Pricing Means (and Why It Matters)

All-in pricing means the listed price covers every component of the program: the clinical consultation with a licensed clinician, the compounded medication (if prescribed), all necessary supplies, and shipping. There is no separate line item for the consultation, no hidden fees at checkout, and no surprise charges after your intake is reviewed.

This is the model New Blue Health uses. For instance, sermorelin is $299 for the 1-month path, all-in (clinical consultation included), or $597 for the 3-month path. NAD+ injectable is $279 for the 1-month path, all-in. Tirzepatide is $349 for the 1-month path or $801 for the 3-month path — again, all-in. Each treatment guide shows the current price and term options that apply at checkout.

Why does this matter beyond convenience? Because the alternative — itemized pricing with a separate consultation fee — creates a perverse incentive. If the consultation is a standalone revenue line, some platforms may be motivated to collect that fee regardless of whether the patient is a good candidate. With all-in pricing there is no separate consultation line to sell: the clinical review is part of one price, and what happens if a prescription is not appropriate is set out in the refund policy rather than in fine print. That keeps the platform's incentive aligned with the patient's interest.

One important nuance: if a licensed clinician determines that a prescription is not appropriate after reviewing your intake, the medication cost is refunded; the consultation terms are set out in the refund policy. There is no separate fee in that structure — the clinical review is simply part of the all-in price.

What's Included in a Typical Peptide Therapy Program

A well-structured peptide therapy program should include all of the following in its quoted price:

If any provider asks you to pay separately for items in this table, that is a pricing structure you should scrutinize carefully. The New Blue Health evaluation guide covers additional red flags in detail.

Some programs also offer multi-month terms at a lower per-month cost. For example, tesamorelin at New Blue Health is $299 for the 1-month path versus $498 for the 2-month path — effectively $249 per month on the longer term. These multi-month options can represent meaningful savings if you and your clinician determine that ongoing use is appropriate.

How the Clinical Consultation Works

The clinical consultation is not a formality. It is a medical evaluation conducted by an independent licensed clinician who reviews your health history, current medications, contraindications, and treatment goals. This clinician is not employed by New Blue Health — the platform facilitates the connection but does not make medical decisions. New Blue Health is a technology and administrative services platform, not a medical provider.

Here is the typical process: you choose a treatment pathway, complete a detailed health intake, and submit your information. A licensed clinician reviews everything and conducts your consultation. If the clinician determines that a prescription is appropriate based on your health profile, the prescription is sent to a licensed partner pharmacy, which ships the medication and supplies directly to you.

Not everyone will qualify. A clinician may determine that a particular therapy is not appropriate based on your medical history, current medications, or other factors. This is exactly how it should work. Any platform that implies everyone qualifies — or that a prescription is a foregone conclusion — is a platform worth avoiding. For guidance on what to ask before starting, see this pre-therapy question guide.

Important for GLP-1 therapies specifically: Semaglutide and tirzepatide carry contraindications for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). A history of pancreatitis is also a clinical concern. These are among the factors a licensed clinician will evaluate during your consultation.

Compounded Medications vs. Commercial Medications: A Pricing Factor

Compounded medications are prepared by state-licensed 503A compounding pharmacies or FDA-registered 503B outsourcing facilities, not commercially manufactured. They are dispensed only with an individual prescription and are not the same as brand-name commercial products. This distinction matters for pricing because compounded formulations typically cost significantly less than their commercially manufactured counterparts.

For context, commercially manufactured semaglutide (the brand-name version) can cost over $1,000 per month without insurance. Compounded semaglutide through New Blue Health is $279 for the 1-month path or $567 for the 3-month path, all-in. That price difference reflects different manufacturing, regulatory and distribution models. For a deeper comparison, the compounded vs. branded medications guide on New Blue Health's blog covers this topic thoroughly.

It is worth understanding the regulatory framework: compounded medications are regulated under state pharmacy boards and applicable federal law, but they are not evaluated through the same commercial approval process as brand-name drugs. New Blue Health's compounding disclosure page explains this in detail.

What to Look for When Comparing Peptide Therapy Providers

Not all telehealth peptide platforms operate with the same level of oversight. Here are specific things to verify:

Red flags to watch for: platforms making promises of specific outcomes, platforms with vague or unverifiable regulatory claims, platforms offering overstated geographic coverage without disclosing state restrictions, and platforms selling compounds without requiring a clinical consultation. The source verification checklist is a practical tool for evaluating any provider you're considering.

Common Pricing Myths About Peptide Therapy

Myth: Cheaper always means better value. A $149 listing that excludes the consultation, supplies, and shipping may cost more than a $299 all-in program. Always compare total out-of-pocket cost for the same supply duration.

Myth: All compounded peptides cost roughly the same. They don't. Tirzepatide is a more complex molecule to compound than sermorelin, which is reflected in the price difference ($349 vs. $299 for the 1-month path at New Blue Health). Topical programs sit at a different point again — GHK-Cu cream starts at $199 and Cashmere Cream is $249 for a 1-month path. The compound, formulation, and delivery format all affect cost.

Myth: The consultation is just a rubber stamp. At any legitimate platform, the clinical consultation involves real medical judgment. Clinicians review contraindications, medication interactions, and health history. Some people will not qualify. If a platform's marketing suggests otherwise, that is a significant concern. Eligibility depends on clinical review, and individual results vary.

Myth: You need insurance to afford peptide therapy. Most compounded peptide programs through telehealth platforms operate outside of insurance. The all-in pricing model means you know your cost upfront. Whether that cost is accessible depends on your budget, but there is no insurance pre-authorization process to navigate.

How New Blue Health Approaches This

New Blue Health operates as a technology and administrative services platform — not a medical provider — that connects patients with independent licensed clinicians and licensed partner pharmacies. Founded by Andy Palenzuela, who has spent 14+ years in regulated health product supply chains, the platform was built around the idea that pricing should be transparent and the clinical process should be genuinely independent. Every price listed on the site includes the clinical consultation, medication (if prescribed), supplies, and shipping. Availability varies by state; see our state availability page. The platform holds LegitScript certification. All educational content is written under the standards outlined on the editorial policy page.

What Happens If You're Not Prescribed

If a licensed clinician determines that a prescription is not appropriate after reviewing your intake, the medication cost is refunded; the consultation terms are set out in the refund policy.

This is a question most platforms don't address clearly, and it's one of the most important financial details to understand before you start.

Before choosing any platform, ask explicitly: what happens financially if a clinician doesn't prescribe? If they can't give you a clear, specific answer, that's a red flag.

Comparing Pricing Models: All-In vs. Itemized

Consider how the same treatment pathway looks under the two models. An itemized platform advertises the medication price alone and adds the consultation, supplies and shipping at checkout; an all-in platform shows one figure that already includes all of them.

The pattern is clear. Itemized models often look cheaper at first glance because they lead with the medication price alone. But once you add the consultation, supplies, and shipping, the total frequently exceeds the all-in price.

Important note for GLP-1 pathways: Semaglutide and tirzepatide are GLP-1 receptor agonists originally studied for metabolic conditions. These medications carry contraindications including a history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN2), and pancreatitis. A licensed clinician will evaluate these contraindications during the clinical review.

State Availability and Other Factors That Affect Access

Availability varies by state; see our state availability page. Patients should verify availability for their specific state and desired pathway before beginning an intake, as provider licensing and pharmacy regulations can vary.

Beyond geography, other factors affect access. Some treatment pathways require specific health criteria. For example, GLP-1 pathways for weight management typically require a minimum BMI or documented metabolic health concerns. A licensed clinician makes these determinations during the clinical review — the platform itself does not make prescribing decisions.

You can check current state availability on New Blue Health's state availability page.

Frequently Asked Questions About Peptide Therapy Pricing

Is the clinical consultation included in the price of peptide therapy?

Yes. At New Blue Health, the clinical consultation is included in the all-in price — it is never a separate or additional fee. If a clinician determines that a prescription is not appropriate, the medication cost is refunded; the consultation terms are set out in the refund policy.

Does everyone qualify for peptide therapy?

No. Eligibility depends on clinical review by an independent licensed clinician. Not everyone will qualify, and a clinician may determine that a particular therapy is not appropriate for you based on your health profile.

What is the regulatory status of compounded medications?

Compounded peptide medications are not commercially manufactured products. They are prepared by state-licensed 503A compounding pharmacies or FDA-registered 503B outsourcing facilities under applicable state and federal regulations. Your clinician can help you understand the options available to you.

How quickly will I have my consultation after signing up?

Consultation timing varies by clinician availability. After completing your intake, an independent licensed clinician will review your information and conduct your consultation. New Blue Health facilitates the scheduling and coordination process.

Is peptide therapy available in my state?

Not in every state. Availability, including any treatment-specific shipping limits, varies by state; see State Availability. An independent licensed clinician decides whether treatment is appropriate, and medication ships only if prescribed.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All medical decisions are made by independent licensed clinicians. Individual results vary. Consult a qualified healthcare professional before starting any therapy.

Written by Andy Palenzuela — founder of New Blue Health, with 14+ years in regulated health product supply chains. Learn more about the New Blue Health Editorial Team.